Cardioprotective Effect of Dexrazoxane in Patients with HER2-Positive Breast Cancer Who Receive Anthracycline Based Adjuvant Chemotherapy Followed by Trastuzumab

PURPOSE: We intended to determine whether dexrazoxane (DZR) is cardioprotective during administration of adjuvant anthracycline-based chemotherapy followed by a 1-year trastuzumab treatment. METHODS: The medical records of 228 patients who underwent surgical resection and received adjuvant chemother...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Breast Cancer
Main Authors: Kim, In-Ho, Lee, Ji Eun, Youn, Ho-Joong, Song, Byung Joo, Chae, Byung Joo
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Breast Cancer Society 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378583/
https://ncbi.nlm.nih.gov/pubmed/28382098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2017.20.1.82
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados